ImportRefusal LogoImportRefusal

Glaxo Wellcome Spain Sa

⚠️ Moderate Risk

FEI: 3002807132 • Tres Cantos • SPAIN

FEI

FEI Number

3002807132

📍

Location

Tres Cantos

🇪🇸

Country

SPAIN
🏢

Address

Tres Cantos, Calle Dr. Severo Ochoa, Tres Cantos, , Spain

Moderate Risk

FDA Import Risk Assessment

33.5
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

2
Total Refusals
2
Unique Violations
8/28/2014
Latest Refusal
3/25/2002
Earliest Refusal

Score Breakdown

Violation Severity
70.0×40%
Refusal Volume
17.7×30%
Recency
0.0×20%
Frequency
1.6×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
8/28/2014
66SCA51TADALAFIL
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/25/2002
64HDL99EXPECTORANT N.E.C.
118NOT LISTED
Florida District Office (FLA-DO)

Frequently Asked Questions

What is Glaxo Wellcome Spain Sa's FDA import refusal history?

Glaxo Wellcome Spain Sa (FEI: 3002807132) has 2 FDA import refusal record(s) in our database, spanning from 3/25/2002 to 8/28/2014.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Glaxo Wellcome Spain Sa's FEI number is 3002807132.

What types of violations has Glaxo Wellcome Spain Sa received?

Glaxo Wellcome Spain Sa has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Glaxo Wellcome Spain Sa come from?

All FDA import refusal data for Glaxo Wellcome Spain Sa is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.